fbpx

Coming soon / May 5, 2021 - May 30, 2021

An overview to INDIBA’s Radiofrequency for the DUAL practitioner (2h CPD) – On-demand

Radiofrequency (RF) is very well known in the human sector but it is an emerging EPA in the veterinary treatment sector. Whether you are treating two or four legged clients, understanding the science behind the technology is the first step on your journey to understanding the possible treatments applications for your clients.

 

Who is this webinar aimed at?

  • Chartered Physiotherapist and Veterinary Physio
  • Chiropractor
  • Osteopath

 

Why should you join this webinar?

  • Discover the science & research behind INDIBA
  • Reports from real cases being treated with INDIBA
  • Discover INDIBA DUAL and the AH-100, and how they fit into your mixed practice

 

WATCH ON DEMAND

AVAILABLE UNTIL MAY 30th 2021. This webinar is free and directed to Chartered Physiotherapist and Veterinary Physios, Chiropractors, Osteopaths.

Our speakers:

Prof. Tim Watson

He has dedicated his work and research to electrotherapies. In the recent years, part of his research has been on INDIBA’s Radiofrequency (RF) technology. In this webinar, Prof. Watson will talk about the studies on the heat effects of RF.

 

Case studies and Q&A with:

Polly Hutson – BSc. MSc. HCPC. ACPAT

Polly is one of the UK’s most experienced INDIBA users having had a device since 2018 and has a DUAL and AH100.

Faye Flood – BSc. MIVCA

Originally from the UK but now living in Ireland, Faye has been treating humans and horses with INDIBA since 2019.

Clare-Maria Campbell – BSc. MSc. HCPC. ACPAT

CMC Physiotherapy purchased the first device off the production line having trialled the VET905 and CT9 device independently during 2020. Clare-Maria will be part of the Q&A session and be able to share her own experience of the device/technology and answer any questions.

Rochelle Dunster – BSc. MSc. HCPC. AACP. ACPAT

Having won our ’12 days of Christmas’ competition earlier this year, Rochelle chose DUAL as the device she wanted. Having only taken delivery of the device in recent months Rochelle can provide a valuable insight into how she has integrated the technology into her clinical practice and her own view as part of the Q&A session.